Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Flow Cytometry: CCR8 Antibody (6B12) [NBP3-26687] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26687_human-ccr8-mab-6b12-282202414312712.jpg "Flow Cytometry: CCR8 Antibody (6B12) [NBP3-26687] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.")
![ELISA: Human CCR8 mAb (6B12) [NBP3-26687] - The Binding Activity of CCR8 with Anti-CCR8 recombinant antibody.Activity: Measured by its binding ability in a functional ELISA. Immobilized Human CCR8 at 5 μg/mL can bind Anti-CCR8 recombinant antibody, the EC50 is 11.20-15.63 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26687_human-ccr8-mab-6b12-elisa-1312025165326..jpg)
![Flow Cytometry: CCR8 Antibody (10A9) [NBP3-26689] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 recombinant antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26689_human-ccr8-mab-10a9-282202414183648.jpg "Flow Cytometry: CCR8 Antibody (10A9) [NBP3-26689] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 recombinant antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.")
![Flow Cytometry: CCR8 Antibody (10A9) [NBP3-26689] - Untransfected HEK293T cells (green line) and transfected Human CCR8 HEK293T stable cells (red line) were stained with anti-CCR8 recombinant antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26689_human-ccr8-mab-10a9-282202414312737.jpg)
![Western Blot: KIR2DS4/CD158i Antibody (C7) [NBP3-41616] - Sample: Lane1: 293T cell lysate; Lane2: Hela cell lysate; Lane3: K562 cell lysate Primary Ab: 3ug/ml NBP3-41616; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41616_mouse-kir2ds4-cd158i-mab-c7-612202421304340.jpg "Western Blot: KIR2DS4/CD158i Antibody (C7) [NBP3-41616] - Sample: Lane1: 293T cell lysate; Lane2: Hela cell lysate; Lane3: K562 cell lysate Primary Ab: 3ug/ml NBP3-41616; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")
![Immunocytochemistry/Immunofluorescence: Fc gamma RIIIA/CD16a Antibody (28C11) [NBP3-26586] - Staining of Hela cell with Fc gamma RIIIA/CD16a Antibody (28C11) at 1:30, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26586_rabbit-fc-gamma-riiia-cd16a-mab-28c11-28220241323618.jpg "Immunocytochemistry/Immunofluorescence: Fc gamma RIIIA/CD16a Antibody (28C11) [NBP3-26586] - Staining of Hela cell with Fc gamma RIIIA/CD16a Antibody (28C11) at 1:30, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG (H+L).")
![ELISA: Mouse TGF-beta 1 ELISA Kit [NBP1-92671]](http://images.novusbio.com/fullsize/Mouse-TGF-beta-1-ELISA-Kit-ELISA-NBP1-92671-img0001.jpg "ELISA: Mouse TGF-beta 1 ELISA Kit [NBP1-92671]")